However, the absolute expression of OXTR in the NETs varies greatly according to the types of primary tumors and is close to the somatostatin receptor type 2 in the small bowel NETs but not in the pancreatic NETs (Sherman et al., 2013). The gene discussed is OXTR; the disease is pancreatic neuroendocrine tumor.